Loading…
Stereotaxis, Inc. is projected to rise to $2.23 by 2027, a +31% move from its current price of $1.70. STXS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.65 | $1.70 | $1.75 | +0.01% |
| Jul 14 | $1.63 | $1.70 | $1.77 | +0.01% |
| Jul 15 | $1.62 | $1.70 | $1.78 | +0.02% |
| Jul 16 | $1.61 | $1.70 | $1.80 | +0.03% |
| Jul 17 | $1.60 | $1.70 | $1.81 | +0.03% |
| Jul 18 | $1.59 | $1.70 | $1.82 | +0.04% |
| Jul 19 | $1.58 | $1.70 | $1.83 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.58 | $1.70 | $1.83 | +0.05% |
| Week 2 | $1.53 | $1.70 | $1.89 | +0.09% |
| Week 3 | $1.50 | $1.70 | $1.93 | +0.14% |
| Week 4 | $1.47 | $1.70 | $1.97 | +0.19% |
| Week 5 | $1.45 | $1.70 | $2.01 | +0.23% |
| Week 6 | $1.42 | $1.70 | $2.04 | +0.28% |
| Week 7 | $1.40 | $1.71 | $2.07 | +0.33% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. It offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems.
It also offers Odyssey, a Synchrony and SynX Solution offer integrated, real-time information solution to manage, control, record and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including MAGiC catheter, a robotically navigated magnetic ablation catheter designed to perform minimally invasive cardiac ablation procedures; MAGiC Sweep, a mapping catheter; QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; and V-CAS devices. Further, it provides interventional devices under the Map-iT, MAGiC, and EMAGIN brands, and other related devices.
It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Stereotaxis, Inc. (STXS) is a healthcare company trading with a current price of $1.77 and a market capitalization of $172.99M, ranked 3940. The stock sits in the Healthcare category and has a 30-day technical picture characterized by BEARISH sentiment, an RSI of 50, and moving averages showing SMA50 at $1.86 and SMA200 at $2.29.
Near-term support is at $1.62 and resistance at $2.08, with a 30-day price range from $1.47 to $2.13. The forecast horizon projects a bullish longer-term trajectory, with averages rising from today’s level toward multi-year targets and sizable potential returns by 2050.
A major floor 21.2% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 22.4% above — a clean break opens room to run.
A major ceiling 32.9% above — clearing it would confirm fresh momentum.
Key STXS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of STXS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.79 | Sell | $1.75 | Sell |
| MA 10 | $1.76 | Sell | $1.77 | Sell |
| MA 20 | $1.77 | Sell | $1.78 | Sell |
| MA 50 | $1.84 | Sell | $1.84 | Sell |
| MA 100 | $1.91 | Sell | $1.94 | Sell |
| MA 200 | $2.25 | Sell | $2.09 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.64 | Neutral |
| Stoch RSI (14) | 37.25 | Neutral |
| CCI (20) | -78.77 | Neutral |
| Williams %R (14) | -70.37 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -2.86 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 29.63 | Neutral |
| TRIX (15) | -0.24 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 43.49 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 1.76 | Sell |
| ADX (14) | 10.47 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture shows BEARISH sentiment. RSI14 is 50, with SMA50 at $1.86 and SMA200 at $2.29. Price action remains between support and resistance, with support at $1.62 and resistance at $2.08. The 30-day range spans from $1.47 to $2.13, reflecting a volatile but bounded near-term path.
The current price of $1.77 sits within this range, indicating limited near-term upside versus downside based on these indicators.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.62 | $1.70 | $2.39 | 0% | Neutral | |
| $1.77 | $2.23 | $2.97 | +31% | Bullish | |
| $1.88 | $2.44 | $3.37 | +43% | Bullish | |
| $1.77 | $2.35 | $3.34 | +38% | Bullish | |
| $1.87 | $2.53 | $3.70 | +49% | Bullish | |
| $1.94 | $2.68 | $4.00 | +58% | Bullish | |
| $1.98 | $2.79 | $4.24 | +64% | Bullish | |
| $2.42 | $3.45 | $5.34 | +103% | Bullish | |
| $2.64 | $3.83 | $6.03 | +125% | Bullish | |
| $2.67 | $3.93 | $6.27 | +131% | Bullish | |
| $3.55 | $5.59 | $9.50 | +229% | Bullish | |
| $5.06 | $8.97 | $16.69 | +428% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.62 | $1.70 | $2.07 | +0.00% |
| August 2026 | $1.47 | $1.74 | $2.11 | +2.25% |
| September 2026 | $1.44 | $1.71 | $2.10 | -1.60% |
| October 2026 | $1.48 | $1.78 | $2.20 | +3.80% |
| November 2026 | $1.56 | $1.87 | $2.34 | +5.60% |
| December 2026 | $1.57 | $1.90 | $2.39 | +1.29% |
Click any year to see its month-by-month STXS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, STXS is projected to trade between $1.62 and $2.39, averaging $1.70 — a potential gain of 0% from today's $1.70. A consolidation phase looks the most probable path here.
Stereotaxis, Inc.'s 2027 outlook centres on $2.23, within a $1.77 to $2.97 range. That is up +31% on the projected 2026 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2028, STXS could reach as high as $3.37, with a base case around $2.44 and support toward $1.88 — roughly +43% from $1.70. Buyers look set to stay in control over this stretch.
Expect STXS to range from $1.77 to $3.34 through 2029. The $2.35 average target implies a +38% move from current prices. That is -4% versus the projected 2028 average. Momentum favours further upside here.
The STXS price prediction for 2030 points to an average of $2.53 (low $1.87, high $3.70) — a potential gain of +49% on today's $1.70. Buyers look set to stay in control over this stretch.
In 2031, STXS is projected to trade between $1.94 and $4.00, averaging $2.68 — a potential gain of +58% from today's $1.70. That is up +6% on the projected 2030 average. Momentum favours further upside here.
Stereotaxis, Inc.'s 2032 outlook centres on $2.79, within a $1.98 to $4.24 range. That is up +4% on the projected 2031 average. That marks a +64% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, STXS could reach as high as $5.34, with a base case around $3.45 and support toward $2.42 — roughly +103% from $1.70. Momentum favours further upside here.
Expect STXS to range from $2.64 to $6.03 through 2034. The $3.83 average target implies a +125% move from current prices. That is up +11% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The STXS price prediction for 2035 points to an average of $3.93 (low $2.67, high $6.27) — a potential gain of +131% on today's $1.70. Momentum favours further upside here.
In 2040, STXS is projected to trade between $3.55 and $9.50, averaging $5.59 — a potential gain of +229% from today's $1.70. That is up +42% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Stereotaxis, Inc.'s 2050 outlook centres on $8.97, within a $5.06 to $16.69 range. That is up +60% on the projected 2040 average. That marks a +428% change versus current levels. Momentum favours further upside here.
Investing $1,000 in STXS today (≈ 588.235294 STXS) could be worth
$5,277.53
+$4,277.53 (+428%) by 2050 · US Dollar
Based on the average projected STXS price of $8.97 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in STXSwould be worth at today's price.
$1,000 invested in STXS on Jul 10, 2025 (≈ 446.42857 STXS) would be worth
$758.93
-$241.07 (-24.1%) today · 0.76× · US Dollar
Based on a STXS entry price of $2.24 vs. today's $1.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.79 | $949.72 | -5.0% |
| 1 month ago | $1.81 | $939.23 | -6.1% |
| 3 months ago | $1.87 | $909.09 | -9.1% |
| 6 months ago | $2.56 | $664.06 | -33.6% |
| 1 year ago | $2.24 | $758.93 | -24.1% |
| All time (5.0y) ago | $9.6 | $177.08 | -82.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our STXS forecast.
Our base-case forecast reaches $3.40 around 2033.
Implied market cap at $3.40: $338.07M
The multi-year forecast portrays a broadly bullish trajectory, with the average price rising from $1.77 in 2026 to $2.78 in 2030, then higher in subsequent years to $6.50 in 2040 and $10.54 in 2050. Notable intermediate milestones include 2027 avg $2.37, 2028 avg $2.61, 2029 avg $2.51, 2031 avg $2.96, 2032 avg $3.10, 2033 avg $3.95, 2034 avg $4.35, and 2035 avg $4.39. The forecast also shows rising ROI, hitting 57% in 2030, 267.3% in 2040, and 495.5% in 2050, with bullish sentiment continuing through 2050.
These figures illustrate a potential long-term upside, but they are estimates and not guarantees. The trajectory depends on market conditions and other factors not specified here.
Tap a question to reveal the answer.
2030 avg is $2.78, with a min of $2.05 and a max of $4.07. The ROI is 57% and the sentiment is BULLISH.
The forecast shows bullish sentiment in 2027–2050, with 2050 avg price of $10.54 and ROI of 495.5%, suggesting substantial upside relative to today’s level, though these are estimates and not guarantees.
2040 forecast shows an average of $6.50 with a max of $11.11 and a min of $4.09, indicating the potential to exceed $5 in that period.
The current price is $1.77 and the market cap is $172.99M.
The 30-day picture shows BEARISH sentiment, RSI14 50, SMA50 $1.86, SMA200 $2.29, with support at $1.62 and resistance at $2.08. The 30-day range is $1.47 to $2.13.
Stereotaxis, Inc. Community Discussion
0Share your Stereotaxis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.